Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
This clinical trial studies the effects of dexrazoxane hydrochloride on biomarkers associated with cardiomyopathy and heart failure after cancer treatment. Studying samples of blood in the laboratory from patients receiving dexrazoxane hydrochloride may help doctors learn more about the effects of dexrazoxane hydrochloride on cells. It may also help doctors understand how well patients respond to treatment.
Research Base: Children's Oncology Group
NCT ID: NCT01790152
NCI Protocol Number: COG-ALTE11C2
For more information see ClinicalTrials.gov
Assessment of Therapy Complications; Laboratory Biomarker Analysis; Quality-of-Life Assessment; Questionnaire Administration
Cancer Survivor, Hodgkin Lymphoma, Leukemia in Remission, Lymphoid Leukemia in Remission, Osteosarcoma